Works matching IS 09024441 AND DT 2022 AND VI 108 AND IP 2

Results: 10

Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre‐ibrutinib era: A population‐based study.

Published in:

European Journal of Haematology, 2022, v. 108, n. 2, p. 145, doi. 10.1111/ejh.13720

By:

Steingrímsson, Vilhjálmur;
Lund, Sigrún H.;
Dickman, Paul W.;
Weibull, Caroline E.;
Björkholm, Magnus;
Landgren, Ola;
Kristinsson, Sigurður Y.

Publication type:

Article

Reasons and consequences of COVID‐19 vaccine failure in patients with chronic lymphocytic leukemia.

Published in:: European Journal of Haematology, 2022, v. 108, n. 2, p. 91, doi. 10.1111/ejh.13722
Publication type:: Article

Bleeding complications in bcr‐abl‐negative myeloproliferative neoplasms (MPN): A retrospective single‐center study of 829 MPN patients.

Published in:

European Journal of Haematology, 2022, v. 108, n. 2, p. 154, doi. 10.1111/ejh.13721

By:

Wille, Kai;
Huenerbein, Karlo;
Jagenberg, Ellen;
Sadjadian, Parvis;
Becker, Tatjana;
Kolatzki, Vera;
Meixner, Raphael;
Marchi, Hannah;
Fuchs, Christiane;
Griesshammer, Martin

Publication type:

Article

Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries.

Published in:

European Journal of Haematology, 2022, v. 108, n. 2, p. 99, doi. 10.1111/ejh.13707

By:

Blimark, Cecilie Hveding;
Vangsted, Annette Juul;
Klausen, Tobias W.;
Gregersen, Henrik;
Szabo, Agoston Gyula;
Hermansen, Emil;
Wålinder, Göran;
Knut‐Bojanowska, Dorota;
Zang, Chenyang;
Turesson, Ingemar

Publication type:

Article

Intracranial hemorrhage in newly diagnosed non‐promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy.

Published in:

European Journal of Haematology, 2022, v. 108, n. 2, p. 125, doi. 10.1111/ejh.13718

By:

Koschade, Sebastian E.;
Stratmann, Jan A.;
Miesbach, Wolfgang;
Steffen, Björn;
Serve, Hubert;
Finkelmeier, Fabian;
Brandts, Christian H.;
Ballo, Olivier

Publication type:

Article

Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series.

Published in:

European Journal of Haematology, 2022, v. 108, n. 2, p. 163, doi. 10.1111/ejh.13717

By:

Tremblay, Zoë;
Wong, Anna;
Otis, Anne‐Sophie;
Pépin, Marie‐Anne;
Bambace, Nadia;
Soulières, Denis;
Bouchard, Philippe;
Adam, Jean‐Philippe

Publication type:

Article

End of treatment FDG‐PET in primary mediastinal B‐cell lymphoma treated with R‐chemotherapy: Prognostic indicator and implications for consolidation radiotherapy.

Published in:

European Journal of Haematology, 2022, v. 108, n. 2, p. 118, doi. 10.1111/ejh.13715

By:

Freitas, Ana Carolina;
Carvalho, Inês Patrocínio;
Esteves, Susana;
Salgado, Lucília;
Gomes da Silva, Maria

Publication type:

Article

Prevalence of non‐adherence and non‐compliance during maintenance therapy in adults with acute lymphoblastic leukemia and their associations with survival.

Published in:

European Journal of Haematology, 2022, v. 108, n. 2, p. 109, doi. 10.1111/ejh.13711

By:

Kristjánsdóttir, Elsa Rán;
Toksvang, Linea Natalie;
Schmiegelow, Kjeld;
Rank, Cecilie Utke

Publication type:

Article

Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non‐interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials.

Published in:

European Journal of Haematology, 2022, v. 108, n. 2, p. 133, doi. 10.1111/ejh.13719

By:

Dechow, Tobias;
Aldaoud, Ali;
Behlendorf, Timo;
Knauf, Wolfgang;
Eschenburg, Henning;
Groschek, Matthias;
Hansen, Richard;
Söling, Ulrike;
Grebhardt, Sina;
Siebenbach, Hans Ulrich;
Vannier, Corinne;
Potthoff, Karin

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2022, v. 108, n. 2, p. 89, doi. 10.1111/ejh.13652
Publication type:: Article